CXCL9 and cancer: The chemotaxis of Tregs to the TME driven by the CCL17/CCL22-CCR4, CCL1-CCR8, CCL28-CCR10, and CXCL9/10/11-CXCR3 axis has also been a widely studied concept among cancer biologists (32).